nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Tension headache—Telbivudine—hepatitis B	0.0945	0.0945	CcSEcCtD
Milnacipran—Urinary hesitation—Lamivudine—hepatitis B	0.0225	0.0225	CcSEcCtD
Milnacipran—Rhabdomyolysis—Telbivudine—hepatitis B	0.0185	0.0185	CcSEcCtD
Milnacipran—Chest discomfort—Telbivudine—hepatitis B	0.0185	0.0185	CcSEcCtD
Milnacipran—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.013	0.013	CcSEcCtD
Milnacipran—Migraine—Telbivudine—hepatitis B	0.0117	0.0117	CcSEcCtD
Milnacipran—Neutropenia—Entecavir—hepatitis B	0.0117	0.0117	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Entecavir—hepatitis B	0.0116	0.0116	CcSEcCtD
Milnacipran—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.011	0.011	CcSEcCtD
Milnacipran—Haematuria—Entecavir—hepatitis B	0.0106	0.0106	CcSEcCtD
Milnacipran—Hepatobiliary disease—Entecavir—hepatitis B	0.0106	0.0106	CcSEcCtD
Milnacipran—Rhabdomyolysis—Lamivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Milnacipran—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0104	0.0104	CcSEcCtD
Milnacipran—Abdominal distension—Telbivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Milnacipran—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Milnacipran—Hepatitis—Entecavir—hepatitis B	0.01	0.01	CcSEcCtD
Milnacipran—Oedema peripheral—Entecavir—hepatitis B	0.00987	0.00987	CcSEcCtD
Milnacipran—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00977	0.00977	CcSEcCtD
Milnacipran—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00976	0.00976	CcSEcCtD
Milnacipran—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00965	0.00965	CcSEcCtD
Milnacipran—Neutropenia—Telbivudine—hepatitis B	0.00961	0.00961	CcSEcCtD
Milnacipran—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00961	0.00961	CcSEcCtD
Milnacipran—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00958	0.00958	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00956	0.00956	CcSEcCtD
Milnacipran—Mental disorder—Entecavir—hepatitis B	0.00878	0.00878	CcSEcCtD
Milnacipran—Malnutrition—Entecavir—hepatitis B	0.00872	0.00872	CcSEcCtD
Milnacipran—Hepatobiliary disease—Telbivudine—hepatitis B	0.00867	0.00867	CcSEcCtD
Milnacipran—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00851	0.00851	CcSEcCtD
Milnacipran—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00838	0.00838	CcSEcCtD
Milnacipran—Hepatitis—Telbivudine—hepatitis B	0.00823	0.00823	CcSEcCtD
Milnacipran—Hypoaesthesia—Telbivudine—hepatitis B	0.00819	0.00819	CcSEcCtD
Milnacipran—Connective tissue disorder—Telbivudine—hepatitis B	0.00809	0.00809	CcSEcCtD
Milnacipran—Leukopenia—Entecavir—hepatitis B	0.00781	0.00781	CcSEcCtD
Milnacipran—Mediastinal disorder—Telbivudine—hepatitis B	0.00742	0.00742	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00737	0.00737	CcSEcCtD
Milnacipran—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00724	0.00724	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00719	0.00719	CcSEcCtD
Milnacipran—Malnutrition—Telbivudine—hepatitis B	0.00716	0.00716	CcSEcCtD
Milnacipran—Infection—Entecavir—hepatitis B	0.00707	0.00707	CcSEcCtD
Milnacipran—Thirst—Lamivudine—hepatitis B	0.00704	0.00704	CcSEcCtD
Milnacipran—Dysgeusia—Telbivudine—hepatitis B	0.00702	0.00702	CcSEcCtD
Milnacipran—Nervous system disorder—Entecavir—hepatitis B	0.00698	0.00698	CcSEcCtD
Milnacipran—Skin disorder—Entecavir—hepatitis B	0.00691	0.00691	CcSEcCtD
Milnacipran—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00681	0.00681	CcSEcCtD
Milnacipran—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0068	0.0068	CcSEcCtD
Milnacipran—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00675	0.00675	CcSEcCtD
Milnacipran—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00662	0.00662	CcSEcCtD
Milnacipran—Migraine—Lamivudine—hepatitis B	0.0066	0.0066	CcSEcCtD
Milnacipran—Insomnia—Entecavir—hepatitis B	0.00644	0.00644	CcSEcCtD
Milnacipran—Somnolence—Entecavir—hepatitis B	0.00633	0.00633	CcSEcCtD
Milnacipran—Dyspepsia—Entecavir—hepatitis B	0.00627	0.00627	CcSEcCtD
Milnacipran—Liver function test abnormal—Lamivudine—hepatitis B	0.00619	0.00619	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Entecavir—hepatitis B	0.00614	0.00614	CcSEcCtD
Milnacipran—Fatigue—Entecavir—hepatitis B	0.00614	0.00614	CcSEcCtD
Milnacipran—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00611	0.00611	CcSEcCtD
Milnacipran—Chest pain—Telbivudine—hepatitis B	0.0061	0.0061	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00606	0.00606	CcSEcCtD
Milnacipran—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00604	0.00604	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.006	0.006	CcSEcCtD
Milnacipran—Abdominal distension—Lamivudine—hepatitis B	0.00583	0.00583	CcSEcCtD
Milnacipran—Gastrointestinal pain—Entecavir—hepatitis B	0.00582	0.00582	CcSEcCtD
Milnacipran—Nervous system disorder—Telbivudine—hepatitis B	0.00573	0.00573	CcSEcCtD
Milnacipran—Thrombocytopenia—Telbivudine—hepatitis B	0.00572	0.00572	CcSEcCtD
Milnacipran—Skin disorder—Telbivudine—hepatitis B	0.00568	0.00568	CcSEcCtD
Milnacipran—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00568	0.00568	CcSEcCtD
Milnacipran—Body temperature increased—Entecavir—hepatitis B	0.00563	0.00563	CcSEcCtD
Milnacipran—Abdominal pain—Entecavir—hepatitis B	0.00563	0.00563	CcSEcCtD
Milnacipran—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00549	0.00549	CcSEcCtD
Milnacipran—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00549	0.00549	CcSEcCtD
Milnacipran—Dysuria—Lamivudine—hepatitis B	0.00542	0.00542	CcSEcCtD
Milnacipran—Neutropenia—Lamivudine—hepatitis B	0.00542	0.00542	CcSEcCtD
Milnacipran—Pollakiuria—Lamivudine—hepatitis B	0.00535	0.00535	CcSEcCtD
Milnacipran—Insomnia—Telbivudine—hepatitis B	0.00529	0.00529	CcSEcCtD
Milnacipran—Paraesthesia—Telbivudine—hepatitis B	0.00525	0.00525	CcSEcCtD
Milnacipran—Dyspepsia—Telbivudine—hepatitis B	0.00515	0.00515	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00512	0.00512	CcSEcCtD
Milnacipran—Asthenia—Entecavir—hepatitis B	0.00511	0.00511	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00505	0.00505	CcSEcCtD
Milnacipran—Fatigue—Telbivudine—hepatitis B	0.00504	0.00504	CcSEcCtD
Milnacipran—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00498	0.00498	CcSEcCtD
Milnacipran—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00491	0.00491	CcSEcCtD
Milnacipran—Hepatobiliary disease—Lamivudine—hepatitis B	0.00489	0.00489	CcSEcCtD
Milnacipran—Diarrhoea—Entecavir—hepatitis B	0.00487	0.00487	CcSEcCtD
Milnacipran—Gastrointestinal pain—Telbivudine—hepatitis B	0.00478	0.00478	CcSEcCtD
Milnacipran—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00475	0.00475	CcSEcCtD
Milnacipran—Dizziness—Entecavir—hepatitis B	0.00471	0.00471	CcSEcCtD
Milnacipran—Hepatitis—Lamivudine—hepatitis B	0.00464	0.00464	CcSEcCtD
Milnacipran—Abdominal pain—Telbivudine—hepatitis B	0.00462	0.00462	CcSEcCtD
Milnacipran—Body temperature increased—Telbivudine—hepatitis B	0.00462	0.00462	CcSEcCtD
Milnacipran—Hypoaesthesia—Lamivudine—hepatitis B	0.00461	0.00461	CcSEcCtD
Milnacipran—Connective tissue disorder—Lamivudine—hepatitis B	0.00456	0.00456	CcSEcCtD
Milnacipran—Vomiting—Entecavir—hepatitis B	0.00453	0.00453	CcSEcCtD
Milnacipran—Rash—Entecavir—hepatitis B	0.00449	0.00449	CcSEcCtD
Milnacipran—Dermatitis—Entecavir—hepatitis B	0.00448	0.00448	CcSEcCtD
Milnacipran—Headache—Entecavir—hepatitis B	0.00446	0.00446	CcSEcCtD
Milnacipran—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00442	0.00442	CcSEcCtD
Milnacipran—Erythema multiforme—Lamivudine—hepatitis B	0.00439	0.00439	CcSEcCtD
Milnacipran—Rash—Adefovir Dipivoxil—hepatitis B	0.00438	0.00438	CcSEcCtD
Milnacipran—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00437	0.00437	CcSEcCtD
Milnacipran—Headache—Adefovir Dipivoxil—hepatitis B	0.00435	0.00435	CcSEcCtD
Milnacipran—Nausea—Entecavir—hepatitis B	0.00423	0.00423	CcSEcCtD
Milnacipran—Asthenia—Telbivudine—hepatitis B	0.0042	0.0042	CcSEcCtD
Milnacipran—Mediastinal disorder—Lamivudine—hepatitis B	0.00418	0.00418	CcSEcCtD
Milnacipran—Chills—Lamivudine—hepatitis B	0.00416	0.00416	CcSEcCtD
Milnacipran—Pruritus—Telbivudine—hepatitis B	0.00414	0.00414	CcSEcCtD
Milnacipran—Nausea—Adefovir Dipivoxil—hepatitis B	0.00412	0.00412	CcSEcCtD
Milnacipran—Malnutrition—Lamivudine—hepatitis B	0.00404	0.00404	CcSEcCtD
Milnacipran—Diarrhoea—Telbivudine—hepatitis B	0.004	0.004	CcSEcCtD
Milnacipran—Flatulence—Lamivudine—hepatitis B	0.00398	0.00398	CcSEcCtD
Milnacipran—Tension—Lamivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Milnacipran—Dysgeusia—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Milnacipran—Dizziness—Telbivudine—hepatitis B	0.00387	0.00387	CcSEcCtD
Milnacipran—Tremor—Lamivudine—hepatitis B	0.00378	0.00378	CcSEcCtD
Milnacipran—Vomiting—Telbivudine—hepatitis B	0.00372	0.00372	CcSEcCtD
Milnacipran—Rash—Telbivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Milnacipran—Dermatitis—Telbivudine—hepatitis B	0.00368	0.00368	CcSEcCtD
Milnacipran—Headache—Telbivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Milnacipran—Syncope—Lamivudine—hepatitis B	0.00362	0.00362	CcSEcCtD
Milnacipran—Leukopenia—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Milnacipran—Loss of consciousness—Lamivudine—hepatitis B	0.00355	0.00355	CcSEcCtD
Milnacipran—Convulsion—Lamivudine—hepatitis B	0.0035	0.0035	CcSEcCtD
Milnacipran—Nausea—Telbivudine—hepatitis B	0.00347	0.00347	CcSEcCtD
Milnacipran—Chest pain—Lamivudine—hepatitis B	0.00344	0.00344	CcSEcCtD
Milnacipran—Anxiety—Lamivudine—hepatitis B	0.00343	0.00343	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00341	0.00341	CcSEcCtD
Milnacipran—Dry mouth—Lamivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Milnacipran—Infection—Lamivudine—hepatitis B	0.00327	0.00327	CcSEcCtD
Milnacipran—Shock—Lamivudine—hepatitis B	0.00324	0.00324	CcSEcCtD
Milnacipran—Nervous system disorder—Lamivudine—hepatitis B	0.00323	0.00323	CcSEcCtD
Milnacipran—Thrombocytopenia—Lamivudine—hepatitis B	0.00323	0.00323	CcSEcCtD
Milnacipran—Skin disorder—Lamivudine—hepatitis B	0.0032	0.0032	CcSEcCtD
Milnacipran—Hyperhidrosis—Lamivudine—hepatitis B	0.00319	0.00319	CcSEcCtD
Milnacipran—Anorexia—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Milnacipran—Hypotension—Lamivudine—hepatitis B	0.00308	0.00308	CcSEcCtD
Milnacipran—Insomnia—Lamivudine—hepatitis B	0.00298	0.00298	CcSEcCtD
Milnacipran—Paraesthesia—Lamivudine—hepatitis B	0.00296	0.00296	CcSEcCtD
Milnacipran—Dyspnoea—Lamivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Milnacipran—Somnolence—Lamivudine—hepatitis B	0.00293	0.00293	CcSEcCtD
Milnacipran—Dyspepsia—Lamivudine—hepatitis B	0.0029	0.0029	CcSEcCtD
Milnacipran—Decreased appetite—Lamivudine—hepatitis B	0.00286	0.00286	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00284	0.00284	CcSEcCtD
Milnacipran—Fatigue—Lamivudine—hepatitis B	0.00284	0.00284	CcSEcCtD
Milnacipran—Constipation—Lamivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Milnacipran—Gastrointestinal pain—Lamivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Milnacipran—Urticaria—Lamivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Milnacipran—Body temperature increased—Lamivudine—hepatitis B	0.0026	0.0026	CcSEcCtD
Milnacipran—Abdominal pain—Lamivudine—hepatitis B	0.0026	0.0026	CcSEcCtD
Milnacipran—Hypersensitivity—Lamivudine—hepatitis B	0.00243	0.00243	CcSEcCtD
Milnacipran—Asthenia—Lamivudine—hepatitis B	0.00236	0.00236	CcSEcCtD
Milnacipran—Pruritus—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Milnacipran—Diarrhoea—Lamivudine—hepatitis B	0.00225	0.00225	CcSEcCtD
Milnacipran—Dizziness—Lamivudine—hepatitis B	0.00218	0.00218	CcSEcCtD
Milnacipran—Vomiting—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Milnacipran—Rash—Lamivudine—hepatitis B	0.00208	0.00208	CcSEcCtD
Milnacipran—Dermatitis—Lamivudine—hepatitis B	0.00208	0.00208	CcSEcCtD
Milnacipran—Headache—Lamivudine—hepatitis B	0.00206	0.00206	CcSEcCtD
Milnacipran—Nausea—Lamivudine—hepatitis B	0.00196	0.00196	CcSEcCtD
